Sutter Health Research Enterprise
8 Medical Plaza Drive
Suite 300
Roseville, CA, 95661
(916) 782-5106
ChellaR@sutterhealth.org
Related Clinical Trials
Adjuvant Breast (EndoPredict Extended Endocrine Trial EXET Myriad)
To evaluate the impact of using EndoPredict clinically to inform treatment decisions
for extended endocrine therapy and the subsequent impact on patient outcome
Investigators: Kristin N. Arreola M.D., Kristie A. Bobolis M.D., Rajeswari Chellappah M.D., Jaspreet K Dhillon Medical Oncologist, Brian K. Kim M.D, Sivakumar Reddy M.D., Nitin Rohatgi MD, Vijay Suhag M.D.
Status: Active, Recruiting
City of Hope 96144 Molecular Genetics Studies of Cancer Patients and Their Relatives
The purpose of this study is to find out how genetics, biologics and behavior might
contribute to
Investigators: Kristin N. Arreola M.D., Kristie A. Bobolis M.D., Rajeswari Chellappah M.D., Brian K. Kim M.D, Sivakumar Reddy M.D., Vijay Suhag M.D.
Status: Active, Recruiting
Locally Advanced (ZEAL-1L GlaxoSmithKline 213400)
Multicenter, randomized, double-blind, placebo-controlled study of niraparib plus
pembrolizumab versus placebo plus pembrolizumab as maintenance therapy
Investigators: Kristin N. Arreola M.D., Deepti Behl MD, Kristie A. Bobolis M.D., Rajeswari Chellappah M.D., Jaspreet K Dhillon Medical Oncologist, Brian K. Kim M.D, Sivakumar Reddy M.D., Vijay Suhag M.D.
Status: Active, Not Recruiting
RESILIENT-Ipsen (MM-398-01-03-04)
A Randomized, Open Label Phase 3 Study of Irinotecan Liposome Injection vs Toptecan
in patients with SCLC
Investigators: Kristin N. Arreola M.D., Deepti Behl MD, Rajeswari Chellappah M.D., Brian K. Kim M.D, Jasdeepa Nagi M.D., Sivakumar Reddy M.D., Nitin Rohatgi MD, Vijay Suhag M.D.
Status: Active, Not Recruiting
Research Studies
Genomic Health Oncotype DX AR-V7
Genomic Health 09-060
Investigators: Kristin N. Arreola M.D., Kristie A. Bobolis M.D., Rajeswari Chellappah M.D., Brian K. Kim M.D, Sivakumar Reddy M.D., Nitin Rohatgi MD, Vijay Suhag M.D., David S Yee M.D., MPH